Difference between revisions of "Basal cell carcinoma"

Jump to navigation Jump to search
967 bytes added ,  18:45, 15 January 2022
(→‎Images: added a case)
 
(5 intermediate revisions by 2 users not shown)
Line 93: Line 93:
Image:Basal_cell_carcinoma_fibroepitheliomatous_pattern_-_very_low_mag.jpg | Fibroepithelioma of Pinkus. (WC/Nephron)
Image:Basal_cell_carcinoma_fibroepitheliomatous_pattern_-_very_low_mag.jpg | Fibroepithelioma of Pinkus. (WC/Nephron)
Image:SkinTumors-P6040209.JPG | Fibroepithelioma of Pinkus. (WC)
Image:SkinTumors-P6040209.JPG | Fibroepithelioma of Pinkus. (WC)
Fiboepithelioma of Pinkus 10x 4.tif | Fiboepithelioma of Pinkus 10x 4.tif (MLA)
Fiboepithelioma of Pinkus 10x 3.tif | Fiboepithelioma of Pinkus 10x 3.tif (MLA)
Fiboepithelioma of Pinkus 10x 2.tif | Fiboepithelioma of Pinkus 10x 2.tif (MLA)
Fiboepithelioma of Pinkus 10x.tif | Fiboepithelioma of Pinkus 10x.tif (MLA)
Fibro of pinkus.tif | Fiboepithelioma of Pinkus 4x.tif (MLA)
</gallery>
</gallery>


Line 199: Line 204:
*[[Ber-EP4]] +ve -- typically weak and focal staining.
*[[Ber-EP4]] +ve -- typically weak and focal staining.
**[[Microcystic adnexal carcinoma]] negative.<ref name=pmid23398472 >{{Cite journal  | last1 = Sellheyer | first1 = K. | last2 = Nelson | first2 = P. | last3 = Kutzner | first3 = H. | last4 = Patel | first4 = RM. | title = The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers. | journal = J Cutan Pathol | volume = 40 | issue = 4 | pages = 363-70 | month = Apr | year = 2013 | doi = 10.1111/cup.12085 | PMID = 23398472 }}</ref>
**[[Microcystic adnexal carcinoma]] negative.<ref name=pmid23398472 >{{Cite journal  | last1 = Sellheyer | first1 = K. | last2 = Nelson | first2 = P. | last3 = Kutzner | first3 = H. | last4 = Patel | first4 = RM. | title = The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers. | journal = J Cutan Pathol | volume = 40 | issue = 4 | pages = 363-70 | month = Apr | year = 2013 | doi = 10.1111/cup.12085 | PMID = 23398472 }}</ref>
*CK5/6 +ve.
*CK5/6 +ve (52 of 52<ref name=pmid18496426/>).
**Useful to assess [[margins]]... if very close.
**Useful to assess [[margins]]... if very close.
*CK7 +ve (30 +ve of 52 cases<ref name=pmid18496426>{{cite journal |authors=Alessi E, Venegoni L, Fanoni D, Berti E |title=Cytokeratin profile in basal cell carcinoma |journal=Am J Dermatopathol |volume=30 |issue=3 |pages=249–55 |date=June 2008 |pmid=18496426 |doi=10.1097/DAD.0b013e31816c828a |url=}}</ref>).
*CK19 -ve/+ve (14 +ve 52<ref name=pmid18496426/>).
*CD10 +ve.
*CD10 +ve.
*Actin +ve.
*Actin +ve.
Line 232: Line 239:
===Electrodesiccation and curettage===
===Electrodesiccation and curettage===
<pre>
<pre>
SKIN LESION, SHAVE BIOPSY WITH ELECTRODESICCATION AND CURETTAGE (EDC):  
Skin, Left Brow, Biopsy with Electrodesiccation and Curettage (EDC):
- BASAL CELL CARCINOMA, margin status assessed clinically during EDC.
</pre>
 
====Block letters====
<pre>
SKIN LESION, LEFT FOREARM, SHAVE BIOPSY WITH ELECTRODESICCATION AND CURETTAGE (EDC):  
- BASAL CELL CARCINOMA, MARGIN STATUS ASSESSED CLINICALLY DURING EDC.  
- BASAL CELL CARCINOMA, MARGIN STATUS ASSESSED CLINICALLY DURING EDC.  
- EXTENSIVE SOLAR ELASTOSIS.
- EXTENSIVE SOLAR ELASTOSIS.
3

edits

Navigation menu